Indegene's IPO is creating a buzz! Find out if you should jump on the bandwagon or stay on the sidelines.
Indegene, a key player in the life sciences industry, has recently launched its Initial Public Offering (IPO), stirring up a frenzy among investors. With shares trading at a premium of ₹246 in the grey market, the company seems to be generating excitement in the financial community. Analysts have given a favorable nod to the IPO, citing Indegene's strong position to capitalize on the growth in the life sciences sector.
Before the IPO launch, Indegene managed to secure a hefty sum of Rs 548.78 crore from anchor investors by offering them 1,21,41,102 equity shares at Rs 452 each. The company aims to raise a massive ₹1841.76 crore through its IPO, reflecting its ambitious expansion plans and market confidence.
The subscription status of the Indegene IPO is drawing attention as analysts recommend investors to subscribe to this opportunity. The healthcare tech service provider is expected to leverage digital adoption in the industry, making it an attractive prospect for potential shareholders.
In the midst of the IPO fervor, the grey market is abuzz with activity, with unlisted Indegene shares trading significantly higher than the issue price. This indicates a strong interest and demand for Indegene's offering, hinting at a positive market reception.
Interestingly, Indegene's IPO is not only about raising funds but also about positioning the company strategically in the evolving healthcare landscape. With a focus on services like drug development, clinical trials, and regulatory submissions, Indegene's IPO represents a significant milestone in its journey towards growth and innovation.
Indegene IPO GMP: Shares of the company are available at a premium of ₹246 in the grey market today, say market observers.
Indegene provides services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, ...
Ahead of its IPO, Indegene raised a total of Rs 548.78 crore from anchor investors by allocating them 1,21,41,102 equity shares at Rs 452 apiece. The initial ...
Analysts advised investors to 'Subscribe' to Indegene IPO, saying the company is well-positioned to benefit from the expected growth in life sciences ...
Indegene अपने IPO के जरिये 1841.76 करोड़ रुपये जुटाना चाहती है। कंपनी की योजना 760 करोड़ रुपये के नए शेयर जारी करने की है।
Indegene IPO Price Updates: The ₹1842-crore initial public offering of healthcare tech service provider Indegene Ltd opens for public subscription today ...
Indegene IPO: प्राइमरी मार्केट में इन्वेस्टमेंट करने वालों के लिए गुड न्यूज है। बायोफार्मास्यूटिकल, एमर्जिंग बायोटेक और मेडिकल डेवाइसेज ...
Indegene IPO Details: Indegene दवा विकास और क्लीनिकल ट्रायल्स, रेगुलेटरी सबमिशंस, फार्माकोविजिलेंस व कंप्लेंट मैनेजमेंट, और प्रोडक्ट्स की ...
Indegene Ltd IPO : इस सप्ताह एक के बाद एक कई बड़े आीपीओ सब्सक्रिप्शन के लिए ओपन होने वाले हैं और इसकी शुरुआत सोमवार को इंडीजीन ...
Indegene IPO GMP Today-1998 में स्थापित इंडेजीन लिमिटेड लाइफ साइंस इंडस्ट्री के लिए सर्विस प्रदान करती है. कंपनी ड्रग डेवलपमेंट ...
Investors can subscribe to this IPO, but should keep a watch on execution post the listing.
According to market observers, unlisted shares of Indegene Ltd are trading Rs 262 higher in the grey market as compared with its issue price.
India Business News: Indegene's IPO, valued at Rs 750 crore, raised Rs 549 crore with top investors like Capital Group. The offering includes OFS with ...
Investors bid for 75.34 lakh equity shares against the total issue size of 2.29 crore shares, stock exchange data showed. Non institutional investors were at ...
ये 8 मई को बंद होगा. कंपनी 1842 करोड़ रुपये का आईपीओ ला रही है. 1,842 करोड़ रुपये के आईपीओ के लिए मूल्य दायरा 430-452 रुपये प्रति शेयर ...
Indegene provides services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, ...
इंडीजीन के इश्यू में 8 मई तक निवेश किया जा सकता है। कंपनी ने आईपीओ में शेयर का प्राइस बैंड 430-452 रुपये रखा है।
Indegene IPO fully subscribed on day one. Non-institutional investors subscribed 4.13 times, retail investors 1.50 times, employees 1.31 times.
The IPO of Indegene Limited was fully subscribed on the first day with retail investors leading the public issue.
इंडिजीन के 1841.75 करोड़ रुपये के आईपीओ के तहत की गई 2,88,66677 शेयरों की पेशकश के मुकाबले 4,80,93837 शेयरों के लिए बोलियां प्राप्त हुईं।
Indegene IPO subscription status: कंपनी इस आईपीओ से 1842 करोड़ रुपये जुटाना चाहती है। आईपीओ में नए शेयर जारी करके हासिल होने वाली आय में ...
Indegene ने 430-452 रुपये का प्राइस बैंड तय किया है और इन्वेस्टर 1 लॉट में 33 शेयरों के लिए बोली लगा सकते हैं. रिटेल इन्वेस्टर के लिए ...
Indegene IPO includes an offer-for-sale of equity shares and a fresh issue totaling ₹1841.76 crore. Various parties are selling their holdings.
Indegene IPO: आईपीओ के तहत non institutional investors की श्रेणी को 4.13 गुना सब्सक्राइब किया गया जबकि retail individual investors का हिस्सा ...
Indegene IPO: The company's shares were trading at a premium of 53% in the grey market over its issue price of Rs 452.
Bengaluru-based Indegene is selling its shares in the price band of Rs 430-452 apiece. Investors can apply for a minimum of 33 shares and its multiples ...
The IPO consists of an OFS of up to 2.93 Crore equity shares by current investors, along with a new equity issue of up to ₹750 Crore.
Indegene IPO sees strong demand on day 2 with 5.09 times subscription, so far. Retail investors and QIBs show healthy interest.
Indegene IPO Subscription Status: कंपनी इस आईपीओ से 1842 करोड़ रुपये जुटाना चाहती है। आईपीओ में नए शेयर जारी करके हासिल होने वाली आय में ...
The Indegene IPO has a price band of Rs 430-452 per share. Interested investors can apply for a minimum of 33 equity shares and in multiples thereafter.
The initial public offering of Indegene continued to receive a healthy response from investors, who bought 21.21 crore equity shares which was 7.35 times ...
At the upper price range of ₹452 per equity share, 36 anchor investors contributed ₹548.77 crore to the Indegene IPO on Friday, May 3.